An article that analyzed proteoglycan expression in prostate cancer tissues found extensive changes in proteoglycan expression in prostate tumors, with a decrease in decorin and lumican expression and an increase in syndecan-1 and glypican-1 expression in tumor stroma and their disappearance in tumor epithelial cells [186]. The gene discussed is DCN; the disease is neoplasm.